Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 16 | 2021 | 350 | 4.170 |
Why?
|
| Alcohol-Related Disorders | 9 | 2021 | 56 | 2.830 |
Why?
|
| Alcohol Drinking | 12 | 2021 | 375 | 2.710 |
Why?
|
| Substance-Related Disorders | 13 | 2021 | 439 | 2.060 |
Why?
|
| Referral and Consultation | 4 | 2017 | 180 | 1.900 |
Why?
|
| Primary Health Care | 11 | 2023 | 848 | 1.590 |
Why?
|
| Opioid-Related Disorders | 7 | 2023 | 168 | 1.580 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2017 | 407 | 1.370 |
Why?
|
| Ambulatory Care | 4 | 2020 | 266 | 1.280 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 444 | 1.170 |
Why?
|
| Mass Screening | 6 | 2020 | 690 | 1.100 |
Why?
|
| Humans | 47 | 2023 | 18430 | 1.060 |
Why?
|
| Ethnic Groups | 8 | 2021 | 501 | 1.030 |
Why?
|
| Social Stigma | 3 | 2017 | 19 | 1.010 |
Why?
|
| Adult | 32 | 2022 | 7910 | 1.000 |
Why?
|
| Male | 31 | 2021 | 10440 | 0.920 |
Why?
|
| Middle Aged | 28 | 2022 | 8284 | 0.900 |
Why?
|
| Mental Disorders | 3 | 2020 | 295 | 0.880 |
Why?
|
| Female | 33 | 2021 | 13136 | 0.850 |
Why?
|
| African Americans | 5 | 2020 | 490 | 0.850 |
Why?
|
| Mobile Applications | 2 | 2019 | 16 | 0.790 |
Why?
|
| Behavior Therapy | 2 | 2023 | 155 | 0.770 |
Why?
|
| United States | 20 | 2021 | 4164 | 0.770 |
Why?
|
| Veterans | 6 | 2020 | 138 | 0.710 |
Why?
|
| Racism | 1 | 2020 | 22 | 0.710 |
Why?
|
| Young Adult | 15 | 2022 | 2518 | 0.700 |
Why?
|
| Suicide, Attempted | 3 | 2020 | 98 | 0.660 |
Why?
|
| Technology | 1 | 2019 | 7 | 0.660 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 342 | 0.640 |
Why?
|
| Translational Medical Research | 1 | 2019 | 39 | 0.640 |
Why?
|
| Family | 2 | 2015 | 120 | 0.580 |
Why?
|
| Buprenorphine | 4 | 2021 | 48 | 0.570 |
Why?
|
| Telemedicine | 2 | 2017 | 184 | 0.540 |
Why?
|
| Continental Population Groups | 2 | 2017 | 315 | 0.530 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 228 | 0.520 |
Why?
|
| Poverty | 1 | 2017 | 182 | 0.520 |
Why?
|
| Transgender Persons | 3 | 2021 | 38 | 0.520 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 5 | 0.510 |
Why?
|
| Twins | 1 | 2015 | 13 | 0.510 |
Why?
|
| Stress, Psychological | 1 | 2016 | 147 | 0.510 |
Why?
|
| Self Report | 3 | 2020 | 256 | 0.510 |
Why?
|
| Stereotyping | 1 | 2014 | 3 | 0.480 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 241 | 0.480 |
Why?
|
| Hispanic Americans | 6 | 2020 | 428 | 0.470 |
Why?
|
| HIV Infections | 2 | 2021 | 695 | 0.470 |
Why?
|
| Social Support | 2 | 2013 | 214 | 0.470 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 1360 | 0.460 |
Why?
|
| Counseling | 1 | 2015 | 197 | 0.450 |
Why?
|
| Opiate Substitution Treatment | 4 | 2021 | 45 | 0.440 |
Why?
|
| Veterans Health | 5 | 2021 | 21 | 0.430 |
Why?
|
| Time Factors | 5 | 2020 | 1136 | 0.410 |
Why?
|
| Perception | 1 | 2012 | 59 | 0.410 |
Why?
|
| Aged | 15 | 2022 | 6417 | 0.390 |
Why?
|
| Outpatients | 3 | 2021 | 111 | 0.370 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2020 | 31 | 0.370 |
Why?
|
| Medical Records | 1 | 2011 | 106 | 0.360 |
Why?
|
| Office Visits | 1 | 2011 | 86 | 0.360 |
Why?
|
| Community Health Services | 1 | 2011 | 86 | 0.360 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 476 | 0.330 |
Why?
|
| United States Department of Veterans Affairs | 6 | 2020 | 126 | 0.320 |
Why?
|
| Mental Health Services | 2 | 2020 | 161 | 0.310 |
Why?
|
| Quality of Health Care | 1 | 2010 | 347 | 0.300 |
Why?
|
| European Continental Ancestry Group | 4 | 2017 | 554 | 0.280 |
Why?
|
| Regression Analysis | 3 | 2019 | 319 | 0.270 |
Why?
|
| Pilot Projects | 4 | 2019 | 237 | 0.260 |
Why?
|
| Cell Phone | 2 | 2017 | 12 | 0.260 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 129 | 0.260 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 724 | 0.260 |
Why?
|
| Adolescent | 10 | 2022 | 3798 | 0.260 |
Why?
|
| Washington | 3 | 2020 | 388 | 0.250 |
Why?
|
| Comorbidity | 3 | 2016 | 619 | 0.240 |
Why?
|
| Prescription Drug Misuse | 2 | 2022 | 11 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2019 | 1296 | 0.220 |
Why?
|
| Crisis Intervention | 2 | 2020 | 16 | 0.220 |
Why?
|
| Minority Groups | 2 | 2020 | 105 | 0.210 |
Why?
|
| Naltrexone | 2 | 2020 | 17 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1173 | 0.190 |
Why?
|
| Psychotherapy | 2 | 2012 | 59 | 0.190 |
Why?
|
| Treatment Adherence and Compliance | 1 | 2021 | 13 | 0.190 |
Why?
|
| Hospitalization | 2 | 2020 | 847 | 0.180 |
Why?
|
| Hawaii | 1 | 2020 | 45 | 0.180 |
Why?
|
| Health Equity | 1 | 2020 | 20 | 0.180 |
Why?
|
| Hepatitis C | 1 | 2021 | 65 | 0.180 |
Why?
|
| Logistic Models | 4 | 2017 | 962 | 0.180 |
Why?
|
| Retrospective Studies | 4 | 2021 | 2550 | 0.180 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 100 | 0.170 |
Why?
|
| Mental Health | 3 | 2020 | 168 | 0.160 |
Why?
|
| Marijuana Abuse | 1 | 2019 | 41 | 0.160 |
Why?
|
| Cannabis | 1 | 2020 | 78 | 0.160 |
Why?
|
| Evidence-Based Medicine | 3 | 2019 | 195 | 0.150 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 19 | 0.150 |
Why?
|
| Risk-Taking | 2 | 2016 | 109 | 0.150 |
Why?
|
| Residential Treatment | 1 | 2017 | 3 | 0.150 |
Why?
|
| Global Health | 1 | 2017 | 33 | 0.150 |
Why?
|
| Narcotic Antagonists | 1 | 2017 | 16 | 0.140 |
Why?
|
| Self-Help Groups | 1 | 2017 | 32 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 382 | 0.140 |
Why?
|
| Health Services Accessibility | 2 | 2011 | 320 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2017 | 198 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 1269 | 0.140 |
Why?
|
| Anxiety Disorders | 2 | 2014 | 93 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2017 | 327 | 0.130 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 270 | 0.130 |
Why?
|
| Gender Identity | 3 | 2021 | 36 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2017 | 310 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 20 | 0.130 |
Why?
|
| Health Surveys | 1 | 2016 | 269 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2017 | 346 | 0.120 |
Why?
|
| Health Resources | 1 | 2015 | 38 | 0.120 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 673 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 567 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2014 | 19 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 392 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 17 | 0.110 |
Why?
|
| Safety-net Providers | 1 | 2014 | 63 | 0.110 |
Why?
|
| Prevalence | 3 | 2021 | 911 | 0.110 |
Why?
|
| Social Environment | 1 | 2013 | 90 | 0.110 |
Why?
|
| Educational Status | 1 | 2013 | 205 | 0.110 |
Why?
|
| Antidepressive Agents | 2 | 2012 | 162 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 399 | 0.100 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 26 | 0.100 |
Why?
|
| Risk Factors | 2 | 2020 | 3449 | 0.100 |
Why?
|
| Salvia | 1 | 2011 | 1 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2011 | 256 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 44 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 17 | 0.090 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 127 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 2003 | 0.090 |
Why?
|
| Hallucinogens | 1 | 2011 | 23 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2011 | 32 | 0.090 |
Why?
|
| Sex Factors | 3 | 2020 | 661 | 0.090 |
Why?
|
| Disease Progression | 1 | 2011 | 271 | 0.090 |
Why?
|
| Physicians | 1 | 2011 | 141 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 232 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2011 | 231 | 0.080 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2009 | 75 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 743 | 0.080 |
Why?
|
| Odds Ratio | 2 | 2019 | 701 | 0.070 |
Why?
|
| Research Design | 2 | 2021 | 402 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1314 | 0.060 |
Why?
|
| Aftercare | 1 | 2022 | 48 | 0.050 |
Why?
|
| Nurse Administrators | 1 | 2021 | 8 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 7 | 0.050 |
Why?
|
| Employee Performance Appraisal | 1 | 2020 | 6 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 91 | 0.050 |
Why?
|
| Benchmarking | 1 | 2020 | 45 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 89 | 0.050 |
Why?
|
| Leadership | 1 | 2020 | 45 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2021 | 56 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 56 | 0.050 |
Why?
|
| Betacoronavirus | 1 | 2020 | 36 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2022 | 153 | 0.040 |
Why?
|
| Checklist | 1 | 2019 | 15 | 0.040 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.040 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 57 | 0.040 |
Why?
|
| Health Services Research | 1 | 2020 | 264 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 36 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 965 | 0.040 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 50 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 872 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 552 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 12 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 292 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2017 | 9 | 0.040 |
Why?
|
| Homosexuality, Female | 1 | 2017 | 8 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2017 | 3 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2017 | 11 | 0.040 |
Why?
|
| Bisexuality | 1 | 2017 | 12 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 51 | 0.040 |
Why?
|
| Pain Management | 1 | 2017 | 59 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 86 | 0.040 |
Why?
|
| Sexual and Gender Minorities | 1 | 2017 | 27 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2017 | 123 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2020 | 747 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 82 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2014 | 45 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2672 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 1389 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 1143 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 342 | 0.030 |
Why?
|
| Personality Disorders | 1 | 2012 | 2 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2012 | 28 | 0.030 |
Why?
|
| Utilization Review | 1 | 2012 | 56 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 34 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 150 | 0.030 |
Why?
|
| Acute Disease | 1 | 2012 | 144 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2011 | 134 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 490 | 0.020 |
Why?
|
| Epidemiologic Factors | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 15 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 598 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2009 | 247 | 0.020 |
Why?
|
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->